ChemicalBook > CAS DataBase List > Demcizumab

Demcizumab

Product Name
Demcizumab
CAS No.
1243262-17-0
Chemical Name
Demcizumab
Synonyms
OMP 21M18;Demcizumab;Demcizumab (anti-DLL4);Research Grade Demcizumab;Research Grade Demcizumab (DHJ65301)
CBNumber
CB48080855
Formula Weight
0
MOL File
Mol file
More
Less

Demcizumab Property

form 
Liquid
color 
Colorless to light yellow
More
Less

Hazard and Precautionary Statements (GHS)

More
Less

Demcizumab Chemical Properties,Usage,Production

Uses

Demcizumab (OMP 21M18) is an anti-DLL4 monoclonal antibody. Demcizumab is a potent inhibitor of the Notch pathway. Demcizumab alone or in combination with chemotherapy is effective in various cancer models[1][2][3].

in vivo

Demcizumab (10 mg/kg, i.p., once a week) together with Irinotecan (7.5 mg/kg) show a significant antitumor effect in KRASWT and KRASMT CRC xenografts[2].
Demcizumab is efficacious alone or in combination with Irinotecan (7.5 mg/kg) in OMP-C8 colon tumors[3].
Demcizumab (20 mg/kg/week, i.p.) increases mice survival in irradiated NRG mice injected PDTALL13 cells[4].

Animal Model:KRASWT and KRASMT CRC xenografts[2]
Dosage:10 mg/kg, together with Irinotecan (HY-16562) (7.5 mg/kg)
Administration:Intraperitoneal injection (i.p.), once a week
Result:Resulted in tumor regression at day 20.

References

[1] Smith DC, et al. A phase I dose escalation and expansion study of the anticancer stem cell agent demcizumab (anti-DLL4) in patients with previously treated solid tumors. Clin Cancer Res. 2014 Dec 15;20(24):6295-303. DOI:10.1158/1078-0432.CCR-14-1373
[2] Fischer?M, et al.?Anti-DLL4 inhibits growth and reduces tumor-initiating cell frequency in colorectal tumors with oncogenic KRAS mutations. Cancer Res?2011;71:1520-5. DOI:10.1158/0008-5472.CAN-10-2817
[3] Hoey?T, et al.?DLL4 blockade inhibits tumor growth and reduces tumor-initiating cell frequency. Cell Stem Cell?2009;5:168–77. DOI:10.1016/j.stem.2009.05.019
[4] Xiong H, et al. Spleen plays a major role in DLL4-driven acute T-cell lymphoblastic leukemia. Theranostics. 2021 Jan 1;11(4):1594-1608. DOI:10.7150/thno.48067

Demcizumab Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

Demcizumab Suppliers

China 20 United States 1 Global 21
TargetMol Chemicals Inc.
Tel
+1-781-999-5354; +17819995354
Email
marketing@targetmol.com
Country
United States
ProdList
32435
Advantage
58

1243262-17-0, DemcizumabRelated Search:

Immunoglobulin G2/G4, anti-(human complement C5) (human-Mus musculus ALXN1210 heavy chain), disulfide with human-Mus musculus ALXN1210 κ-chain, dimer Begelomab Simridarlimab Cilgavimab Birtamimab Gancotamab Anumigilimab Lacutamab Telimomabaritox Tomaralimab

  • Demcizumab
  • Research Grade Demcizumab (DHJ65301)
  • OMP 21M18
  • Research Grade Demcizumab
  • Demcizumab (anti-DLL4)
  • 1243262-17-0